MMP9-Sensitive PEG-Shedding Nanoliposomes for Targeted Codelivery of Erlotinib and Doxorubicin to MDA-MB-231 Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MMP9-Sensitive PEG-Shedding Nanoliposomes for Targeted Codelivery of Erlotinib and Doxorubicin to MDA-MB-231 Cells

Published:2021-11-02 Issue:11 Volume:3 Page:5982-5998
ISSN:2637-6105
Container-title:ACS Applied Polymer Materials
language:en
Short-container-title:ACS Appl. Polym. Mater.

Author:

Kim So-Yeon¹²,Yoon Ji Young³,Lee Haesoo⁴,Cho Cheong-Weon⁴,Seong Hasoo¹^ORCID

Affiliation:

1. Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea

2. Department of Polymer Science & Engineering, Chungnam National University, Daejeon 34134, Republic of Korea

3. Bioconvergence Analysis, Korea Basic Science Institute, Cheongju-si 28119, Republic of Korea

4. College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea

Funder

Korea Research Institute of Chemical Technology

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Polymers and Plastics,Process Chemistry and Technology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsapm.1c01228

Reference47 articles.

1. Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

2. Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance

3. Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance

4. Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

5. Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy;Molecular Pharmaceutics;2023-01-02

2. Nanoliposomes as safe and efficient drug delivery nanovesicles;Advanced and Modern Approaches for Drug Delivery;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3